Medicxi Ventures Management (jersey) LTD
CIK:0001715579
Investment Adviser
$438M AUM
5 holdings
St. Helier, Jersey (Crown Dependency), United Kingdom
Medicxi is a European investment firm specializing in life sciences sector investments, with a focus on supporting biotech and pharmaceutical companies at various stages of development, from seed to late-stage
Investment Strategy
Life sciences and healthcare equity investments, particularly in biotech and pharmaceutical companies, leveraging both early-stage innovation and opportunities in clinical and commercial development
Top Buys
C
CNTACENTESSA PHARMACEUTICALS PLC+$221.8M
N
NAMSNEWAMSTERDAM PHARMA COMPANY+$29.6M
P
PHATPHATHOM PHARMACEUTICALS INC+$16.3M
A
AURAAURA BIOSCIENCES INC-$243.2K
Top Sells
C
CNTACENTESSA PHARMACEUTICALS PLC+$221.8M
N
NAMSNEWAMSTERDAM PHARMA COMPANY+$29.6M
R
RAPTRAPT THERAPEUTICS INC-$22.4M
P
PHATPHATHOM PHARMACEUTICALS INC+$16.3M
A
AURAAURA BIOSCIENCES INC-$243.2K
Top Holdings
C
CNTACENTESSA PHARMACEUTICALS PLC+65.0%$484.1M
P
PHATPHATHOM PHARMACEUTICALS INC+11.8%$87.9M
N
NAMSNEWAMSTERDAM PHARMA COMPANY+11.0%$81.6M
A
AURAAURA BIOSCIENCES INC+2.5%$18.8M
Equity Positions (4)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CNTA | CENTESSA PHARMACEUTICALS PLC | 65.03% | $484.1M | 19,963,157 | $20.88 | $24.25 | +$221.8M |
P PHAT | PHATHOM PHARMACEUTICALS INC | 11.80% | $87.9M | 7,464,572 | $16.82 | $11.77 | +$16.3M |
N NAMS | NEWAMSTERDAM PHARMA COMPANY | 10.96% | $81.6M | 2,869,565 | $11.20 | $28.44 | +$29.6M |
A AURA | AURA BIOSCIENCES INC | 2.52% | $18.8M | 3,039,892 | $16.98 | $6.18 | -$243.2K |
Industry Allocation
PHARMACEUTICAL PREPARATIONS
+87.8%
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
+2.5%